Chemring to deliver joint biological point detection systems for US forces

Chemring Detection Systems has received a production and delivery order for 32 joint biological point detection systems (JBPDS), as part of the $25.2m full rate production contract by the Aberdeen Contracting Command.

Under the order, the company will deliver JBPDS for installation in the Stryker Nuclear Biological Chemical Reconnaissance Vehicle (NBCRV) as well as associated spare parts and services.

Chemring Detection CEO Mark Papworth said that the company will continue to with the US Army to provide Joint Biological Point Detection capability for military.

"With over 875 systems currently delivered to US Forces, the JBPDS continues to provide early warning and identification of biological warfare agents, thereby limiting the effects of biological attacks that have the potential for catastrophic effects on the warfighters," Papworth added.

In addition to communicating threat information over standard communication systems, the JBPDS will provide automatic detection and identification of airborne biological agents at very low levels and triggers local and remote warning systems.

The Joint Program Executive Office for Chemical and Biological Defense (JPEO-CBD) manages the JBPDS programme, which has also undergone the whole system live agent test (WSLAT).

Deliveries under the contract will begin from March 2014 and run through July 2014, while work will be carried out at the company’s facility in Charlotte, North Carolina, US.